• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Myelodysplastic syndromes with bone marrow fibrosis.

作者信息

Della Porta Matteo Giovanni, Malcovati Luca

出版信息

Haematologica. 2011 Feb;96(2):180-3. doi: 10.3324/haematol.2010.039875.

DOI:10.3324/haematol.2010.039875
PMID:21282718
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3031682/
Abstract
摘要

相似文献

1
Myelodysplastic syndromes with bone marrow fibrosis.伴有骨髓纤维化的骨髓增生异常综合征
Haematologica. 2011 Feb;96(2):180-3. doi: 10.3324/haematol.2010.039875.
2
Allogeneic stem cell transplantation for myelodysplastic syndromes with bone marrow fibrosis.异基因造血干细胞移植治疗骨髓纤维化伴骨髓增生异常综合征。
Haematologica. 2011 Feb;96(2):291-7. doi: 10.3324/haematol.2010.031229. Epub 2010 Oct 22.
3
Reduced intensity transplantation: where are we now?减低预处理强度移植：我们现在处于什么阶段？
Hematol J. 2004;5 Suppl 3:S34-8. doi: 10.1038/sj.thj.6200419.
4
Early Improvement in Marrow Fibrosis Following Haploidentical Stem Cell Transplantation for a Patient with Myelodysplastic Syndrome with Bone Marrow Fibrosis.单倍体相合干细胞移植治疗骨髓增生异常综合征伴骨髓纤维化患者后骨髓纤维化的早期改善
Intern Med. 2016;55(22):3351-3356. doi: 10.2169/internalmedicine.55.6435. Epub 2016 Nov 15.
5
Marrow fibrosis as a risk factor for posttransplantation outcome in patients with advanced myelodysplastic syndrome or acute myeloid leukemia with multilineage dysplasia.骨髓纤维化作为晚期骨髓增生异常综合征或伴有多系发育异常的急性髓系白血病患者移植后结局的一个危险因素。
Biol Blood Marrow Transplant. 2007 Mar;13(3):345-54. doi: 10.1016/j.bbmt.2006.10.030.
6
Haploidentical bone marrow transplantation in patients with advanced myelodysplastic syndrome.单倍型相合骨髓移植治疗晚期骨髓增生异常综合征患者
Am J Hematol. 2017 Jun;92(6):E117-E119. doi: 10.1002/ajh.24725. Epub 2017 Apr 29.
7
Graft-versus-Host Disease-Free, Relapse-Free Survival after Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome.异基因造血干细胞移植治疗骨髓增生异常综合征后无移植物抗宿主病、无复发生存。
Biol Blood Marrow Transplant. 2019 Jan;25(1):63-72. doi: 10.1016/j.bbmt.2018.08.004. Epub 2018 Aug 10.
8
A randomised study of allogeneic transplantation with stem cells from blood or bone marrow.
Bone Marrow Transplant. 2000 Jun;25(11):1129-36. doi: 10.1038/sj.bmt.1702422.
9
A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome.对于骨髓增生异常综合征患者，采用基于氟达拉滨的剂量降低预处理方案，随后接受来自相关或无关供体的异基因干细胞移植。
Bone Marrow Transplant. 2001 Oct;28(7):643-7. doi: 10.1038/sj.bmt.1703215.
10
Reduced-intensity hematopoietic stem cell transplantation for a patient with myelodysplastic syndrome and chronic obstructive pulmonary disease.低强度造血干细胞移植治疗一名骨髓增生异常综合征合并慢性阻塞性肺疾病患者
Int J Hematol. 2004 Dec;80(5):470-1. doi: 10.1532/ijh97.04126.

引用本文的文献

1
Impact of bone marrow fibrosis on outcomes of allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia.骨髓纤维化对急性髓系白血病异基因造血干细胞移植结局的影响。
Bone Marrow Transplant. 2024 Dec;59(12):1654-1666. doi: 10.1038/s41409-024-02402-3. Epub 2024 Aug 27.
2
Bone marrow fibrosis in newly diagnosed multiple myeloma and its correlation with clinicopathological factors.初诊多发性骨髓瘤患者骨髓纤维化及其与临床病理因素的相关性。
Diagn Pathol. 2024 Jul 18;19(1):99. doi: 10.1186/s13000-024-01516-y.
3
Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasms.2022 年世界卫生组织分类与骨髓增生异常综合征/肿瘤国际共识分类的比较。
Blood Cancer J. 2024 Apr 9;14(1):57. doi: 10.1038/s41408-024-01031-9.
4
Impact of myelofibrosis on patients with myelodysplastic syndromes following allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后骨髓纤维化对骨髓增生异常综合征患者的影响。
J Transl Med. 2024 Mar 13;22(1):275. doi: 10.1186/s12967-024-05080-3.
5
Cancer and Diabetes: Predictive Factors in Patients with Metabolic Syndrome.癌症与糖尿病：代谢综合征患者的预测因素
Diagnostics (Basel). 2023 Aug 11;13(16):2647. doi: 10.3390/diagnostics13162647.
6
Histiocytoid giant cellulitis-like Sweet syndrome at the site of sternal aspiration: A case report and review of literature.胸骨穿刺部位出现的组织细胞样巨细胞性蜂窝织炎样Sweet综合征：一例报告并文献复习
World J Clin Cases. 2022 Sep 26;10(27):9768-9775. doi: 10.12998/wjcc.v10.i27.9768.
7
Personalized Risk Schemes and Machine Learning to Empower Genomic Prognostication Models in Myelodysplastic Syndromes.个性化风险方案和机器学习赋能骨髓增生异常综合征的基因组预后模型。
Int J Mol Sci. 2022 Mar 3;23(5):2802. doi: 10.3390/ijms23052802.
8
BMT for Myelodysplastic Syndrome: When and Where and How.骨髓增生异常综合征的骨髓移植：时机、地点与方式
Front Oncol. 2022 Jan 6;11:771614. doi: 10.3389/fonc.2021.771614. eCollection 2021.
9
Myelodysplastic Syndromes with Bone Marrow Fibrosis: An Update.骨髓纤维化伴骨髓增生异常综合征：最新进展。
Ann Lab Med. 2022 May 1;42(3):299-305. doi: 10.3343/alm.2022.42.3.299.
10
Machine Learning of Bone Marrow Histopathology Identifies Genetic and Clinical Determinants in Patients with MDS.机器学习分析骨髓组织病理学鉴别 MDS 患者的遗传和临床决定因素
Blood Cancer Discov. 2021 Mar 22;2(3):238-249. doi: 10.1158/2643-3230.BCD-20-0162. eCollection 2021 May.

本文引用的文献

1
Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome.基于疾病状态和骨髓增生异常综合征患者的血液外合并症的风险分层。
Haematologica. 2011 Mar;96(3):441-9. doi: 10.3324/haematol.2010.033506. Epub 2010 Dec 6.
2
Allogeneic stem cell transplantation for myelodysplastic syndromes with bone marrow fibrosis.异基因造血干细胞移植治疗骨髓纤维化伴骨髓增生异常综合征。
Haematologica. 2011 Feb;96(2):291-7. doi: 10.3324/haematol.2010.031229. Epub 2010 Oct 22.
3
Silver Impregnation of Reticulum in Paraffin Sections.石蜡切片中网织纤维的银浸染法
Am J Pathol. 1937 Nov;13(6):993-1002.5.
4
Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study.异基因造血干细胞移植治疗骨髓增生异常综合征患者移植前输血史和继发铁过载对预后的影响：一项 GITMO 研究。
Haematologica. 2010 Mar;95(3):476-84. doi: 10.3324/haematol.2009.011429. Epub 2009 Nov 10.
5
Reticulin accumulation in essential thrombocythemia: prognostic significance and relationship to therapy.原发性血小板增多症中的网状纤维沉积：预后意义及与治疗的关系
J Clin Oncol. 2009 Jun 20;27(18):2991-9. doi: 10.1200/JCO.2008.20.3174. Epub 2009 Apr 13.
6
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.世界卫生组织（WHO）髓系肿瘤和急性白血病分类的2008年修订版：基本原理及重要变化
Blood. 2009 Jul 30;114(5):937-51. doi: 10.1182/blood-2009-03-209262. Epub 2009 Apr 8.
7
Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes.原发性骨髓增生异常综合征中骨髓纤维化和CD34阳性细胞簇的临床相关性
J Clin Oncol. 2009 Feb 10;27(5):754-62. doi: 10.1200/JCO.2008.18.2246. Epub 2008 Dec 22.
8
WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).世界卫生组织分类和WPSS预测骨髓增生异常综合征患者移植后的结局：来自意大利骨髓移植协作组（GITMO）的一项研究。
Blood. 2008 Aug 1;112(3):895-902. doi: 10.1182/blood-2008-03-143735. Epub 2008 May 22.
9
Marrow fibrosis predicts early fatal marrow failure in patients with myelodysplastic syndromes.骨髓纤维化预示骨髓增生异常综合征患者早期致命性骨髓衰竭。
Leukemia. 2008 Feb;22(2):313-22. doi: 10.1038/sj.leu.2405030. Epub 2007 Nov 22.
10
Prognostic implications of the European consensus for grading of bone marrow fibrosis in chronic idiopathic myelofibrosis.欧洲慢性特发性骨髓纤维化骨髓纤维化分级共识的预后意义
Blood. 2008 Feb 15;111(4):1862-5. doi: 10.1182/blood-2007-09-112953. Epub 2007 Nov 20.